|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
PROLOGUESpecialty Hospitals: Issues To ConsiderThe problem of specialty hospitals recapitulates the issues outlined in the first section of this volume. The following three papers show in detail what increased price competition in the hospital sector looks like and what implications it has for the mission of community hospitals. These papers are meant to inform a specific policy debate that has been simmering on Capitol Hill for several years, but they deserve to be read in a larger context as well. The cardiac, orthopedic, and surgical hospitals examined in these studies represent just a part of a wider trend toward increasingly competitive and entrepreneurial provision of services throughout the health sector. The growth of single-specialty office practices is another component of the trend, along with the efforts of hospitals to package and promote competitive specialty service programs. The debate over specialty hospitals is often construed by noncombatants as simple interest-group politics: Community hospitals are perceived as fighting to protect their revenues against the inroads of competitors, which are seen alternatively as exemplars of efficiency or opportunistic cream skimmers. In the larger context, though, the issues are not so simple. A decade ago, "market-driven reform" meant competition between integrated delivery organizations whose incentive for quality and efficiency derived from the capitated payments they received. Specialty competition and price transparency are fee-for-service strategies that exacerbate the distress of the multispecialty medical groups that thrived under capitation and were the darlings of the policy community a decade ago. Thus, it is not just community hospitals that feel besieged by the specter of increasing price competition. The papers that follow represent work that was commissioned by Congress in the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003. They do not settle the specialty hospital issue raised by MMA. Rather, they contribute a careful marshaling of the evidence and a review of key analytical issues for those who want an opportunity to think the problem through for themselves. Stuart Gutermans scrupulously balanced overview frames the questions that Congress has on its plate. Leslie Greenwald and colleagues from the Research Triangle Institute were commissioned by the Centers for Medicare and Medicaid Services (CMS) to examine the effects of physicians ownership of specialty hospitals; their paper is based on that research. Jeff Stensland and Ariel Winter worked on the Medicare Payment Advisory Commissions (MedPACs) analysis of utilization patterns in physician-owned specialty hospitals; they discuss their findings here. Chip Kahn, president and CEO of the Federation of American Hospitals, contributes a Perspective.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||